Unity Biotechnology, Inc. announced the closing of an additional $35 million in Series B financing. This second close of the Series B, in addition to the initial close in fall of 2016, brings the total amount of this financing to $151 million. UNITY also announced that Graham Cooper has joined UNITY's board of directors. Mr. Cooper was previously the chief financial officer of Receptos, which was acquired by Celgene in 2015 for $7.8 billion.